{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:52:12Z","timestamp":1792839132435,"version":"4.5.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2556,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>\n                                 <jats:bold>Hyponatremia is a frequent complication of advanced cirrhosis related to an impairment in the renal capacity to eliminate solute-free water that causes a retention of water that is disproportionate to the retention of sodium, thus causing a reduction in serum sodium concentration and hypo-osmolality. The main pathogenic factor responsible for hyponatremia is a nonosmotic hypersecretion of arginine vasopressin (or antidiuretic hormone) from the neurohypophysis related to circulatory dysfunction. Hyponatremia in cirrhosis is associated with increased morbidity and mortality. There is evidence suggesting that hyponatremia may affect brain function and predispose to hepatic encephalopathy. Hyponatremia also represents a risk factor for liver transplantation as it is associated with increased frequency of complications and impaired short-term survival after transplantation. The current standard of care based on fluid restriction is unsatisfactory. Currently, a new family of drugs, known as vaptans, which act by antagonizing specifically the effects of arginine vasopressin on the V2 receptors located in the kidney tubules, is being evaluated for their role in the management of hyponatremia. The short-term treatment with vaptans is associated with a marked increase in renal solute\u2013free water excretion and improvement of hyponatremia. Long-term administration of vaptans seems to be effective in maintaining the improvement of serum sodium concentration, but the available information is still limited. Treatment with vaptans represents a novel approach to improving serum sodium concentration in cirrhosis. (Hepatology 2008.)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.22418","type":"journal-article","created":{"date-parts":[[2008,5,16]],"date-time":"2008-05-16T18:19:45Z","timestamp":1210961985000},"page":"1002-1010","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":252,"title":["Hyponatremia in cirrhosis: Pathogenesis, clinical significance, and management"],"prefix":"10.1097","volume":"48","author":[{"given":"Pere","family":"Gin\u00e8s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-32-20241202","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI102390","article-title":"Electrolyte studies on patients with cirrhosis of the liver.","volume":"29","author":"Eisenmenger","year":"1950","journal-title":"J Clin Invest"},{"key":"R3-32-20241202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01095898","article-title":"Prognostic value of spontaneous hyponatremia in cirrhosis with ascites.","volume":"21","author":"Arroyo","year":"1976","journal-title":"Am J Dig Dis"},{"key":"R4-32-20241202","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0016-5085(88)90441-6","article-title":"Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.","volume":"94","author":"Llach","year":"1988","journal-title":"Gastroenterology"},{"key":"R5-32-20241202","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.","volume":"40","author":"Heuman","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R6-32-20241202","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/lt.20329","article-title":"Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.","volume":"11","author":"Ruf","year":"2005","journal-title":"Liver Transpl"},{"key":"R7-32-20241202","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1136\/gut.2006.102764","article-title":"MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.","volume":"56","author":"Londono","year":"2007","journal-title":"Gut"},{"key":"R8-32-20241202","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","article-title":"Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation.","volume":"130","author":"Londono","year":"2006","journal-title":"Gastroenterology"},{"key":"R9-32-20241202","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/lt.21154","article-title":"The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study.","volume":"13","author":"Dawwas","year":"2007","journal-title":"Liver Transpl"},{"key":"R10-32-20241202","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.semnephrol.2006.02.003","article-title":"Vaptans and the treatment of waterretaining disorders.","volume":"26","author":"Quittnat","year":"2006","journal-title":"Semin Nephrol"},{"key":"R11-32-20241202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510280337","article-title":"Hyponatremia in cirrhosis: from pathogenesis to treatment.","volume":"28","author":"Gines","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R12-32-20241202","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey.","volume":"44","author":"Angeli","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R14-32-20241202","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia.","volume":"342","author":"Adrogue","year":"2000","journal-title":"N Engl J Med"},{"key":"R15-32-20241202","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM200005183422006","article-title":"Hypernatremia.","volume":"342","author":"Adrogue","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R16-32-20241202","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.amjmed.2006.05.003","article-title":"Brain volume regulation in response to hypoosmolality and its correction.","volume":"119","author":"Sterns","year":"2006","journal-title":"Am J Med"},{"key":"R17-32-20241202","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1172\/JCI117728","article-title":"Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.","volume":"95","author":"Videen","year":"1995","journal-title":"J Clin Invest"},{"key":"R18-32-20241202","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0016-5085(94)90552-5","article-title":"Proton magnetic resonance spectroscopy studies on human brain myoinositol in hypoosmolarity and hepatic encephalopathy.","volume":"107","author":"Haussinger","year":"1994","journal-title":"Gastroenterology"},{"key":"R19-32-20241202","first-page":"185","article-title":"Glutamine, myoinositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammoniainduced brain edema.","volume":"32","author":"Cordoba","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R20-32-20241202","first-page":"1622","article-title":"Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis.","volume":"1613-","author":"Restuccia","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R21-32-20241202","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/hep.21235","article-title":"Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis.","volume":"43","author":"Haussinger","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R22-32-20241202","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0168-8278(01)00181-7","article-title":"The development of lowgrade cerebral edema in cirrhosis is supported by the evolution of (1)Hmagnetic resonance abnormalities after liver transplantation.","volume":"35","author":"Cordoba","year":"2001","journal-title":"J Hepatol"},{"key":"R23-32-20241202","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/hep.21114","article-title":"Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy.","volume":"43","author":"Kale","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R24-32-20241202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-8278(01)00129-5","article-title":"Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients.","volume":"35","author":"Amodio","year":"2001","journal-title":"J Hepatol"},{"key":"R25-32-20241202","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0168-8278(95)80325-4","article-title":"Analysis of prognostic variables in the prediction of shunt failure, variceal rebleeding, early mortality and encephalopathy following the transjugular intrahepatic portosystemic stentshunt (TIPSS).","volume":"23","author":"Jalan","year":"1995","journal-title":"J Hepatol"},{"key":"R26-32-20241202","first-page":"233A","article-title":"Hyponatremia predisposes to hepatic encephalopathy in patients with cirrhosis. Results of a prospective study with timedependent analysis. Abstract.","volume":"44","author":"Baccaro","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R27-32-20241202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: course, predictive factors and prognosis.","volume":"20","author":"Follo","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R28-32-20241202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis.","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"R29-32-20241202","first-page":"567A","article-title":"Hyponatremia is a major determinant of impaired healthrelated quality of life in cirrhosis with ascites Abstract.","volume":"46","author":"Gines","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R30-32-20241202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1399-0012.1998.tb01102.x","article-title":"Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis.","volume":"12","author":"Abbasoglu","year":"1998","journal-title":"Clin Transplant"},{"key":"R31-32-20241202","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/00007890-198912000-00023","article-title":"Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium.","volume":"48","author":"Wszolek","year":"1989","journal-title":"Transplantation"},{"key":"R32-32-20241202","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","article-title":", for the VPA Study Group. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized doubleblind multicenter trial.","volume":"124","author":"Gerbes","year":"2003","journal-title":"Gastroenterology"},{"key":"R34-32-20241202","doi-asserted-by":"crossref","first-page":"90A","DOI":"10.1016\/S0168-8278(07)61688-2","article-title":"Wong F, Watson H. Longterm improvement of serum sodium by the V2receptor antagonist satavaptan in patients with cirrhosis and hyponatremia. Abstract.","volume":"46","author":"Gines","year":"2007","journal-title":"J Hepatol"},{"key":"R35-32-20241202","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gut.31.2.204","article-title":"Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites.","volume":"31","author":"McCormick","year":"1990","journal-title":"Gut"},{"key":"R36-32-20241202","doi-asserted-by":"crossref","first-page":"232A","DOI":"10.1016\/S0168-8278(07)61830-3","article-title":"Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trail. Abstract.","volume":"46","author":"Jalan","year":"2007","journal-title":"J Hepatol"},{"key":"R37-32-20241202","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/jhep.2002.36375","article-title":"Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.","volume":"36","author":"Guyader","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R38-32-20241202","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2003.50021","article-title":"A vasopressin receptor antagonist (VPA985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebocontrolled trial.","volume":"37","author":"Wong","year":"2003","journal-title":"HEPATOLOGY"},{"issue":"Suppl","key":"R39-32-20241202","first-page":"691A","article-title":"Effects of a selective vasopressin V2 receptor antagonist, satavaptan (SR121463B), in patients with cirrhosis and ascites without hyponatremia. Abstract.","volume":"44","author":"Gines","year":"2006","journal-title":"HEPATOLOGY"},{"issue":"Suppl","key":"R40-32-20241202","first-page":"180A","article-title":"Effects of a selective vasopressin V2 receptor antagonist, satavaptan (SR121463B), on recurrence of ascites after large volume paracentesis. Abstract.","volume":"44","author":"Wong","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R41-32-20241202","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0009-9236(98)90107-2","article-title":"Therapeutic and diagnostic potential of a vasopressin2 antagonist for impaired water handling in cirrhosis.","volume":"63","author":"Inoue","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"RU42-32-20241202","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1365-2036.2006.03088.x","article-title":"Oral V2 receptor antagonist (RWJ351647) in patients with cirrhosis and ascites: a randomized, doubleblind, placebocontrolled, single ascending dose study.","volume":"24","author":"Thuluvath","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl","key":"R44-32-20241202","first-page":"LB19A","article-title":"Randomized, placebocontrolled trial of tolvaptan, a novel V2receptor antagonist, in hyponatremia: results of the SALT 2 trial with emphasis on efficacy and safety in cirrhosis. Abstract.","volume":"42","author":"Afdhal","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R45-32-20241202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1067\/mlc.2001.116025","article-title":"Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA985J.","volume":"138","author":"Decaux","year":"2001","journal-title":"Lab Clin Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22418","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200809000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:06:30Z","timestamp":1733159190000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200809000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22418","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}